Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+10.75%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$34.5B
AUM Growth
+$1.42B
(+4.3%)
Cap. Flow
-$1.84B
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
11.63%
Holding
2,029
New
471
Increased
426
Reduced
415
Closed
423
Top Buys
| 1 |
Broadcom
AVGO
|
$623M |
| 2 |
Fox Class A
FOXA
|
$284M |
| 3 |
Edwards Lifesciences
EW
|
$284M |
| 4 |
PayPal
PYPL
|
$282M |
| 5 |
AT&T
T
|
$269M |
Top Sells
| 1 |
Dell
DELL
|
$446M |
| 2 |
Meta Platforms (Facebook)
META
|
$379M |
| 3 |
Union Pacific
UNP
|
$291M |
| 4 |
NVIDIA
NVDA
|
$275M |
| 5 |
Johnson Controls International
JCI
|
$252M |
Sector Composition
| 1 | Technology | 18.4% |
| 2 | Healthcare | 16.64% |
| 3 | Consumer Discretionary | 12.5% |
| 4 | Industrials | 11.7% |
| 5 | Energy | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Quest Diagnostics
DGX
$20.5B
| $12.4M | 0.03% |
93,100
-49,269
| -35% | -$6.56M |
|
527
Darling Ingredients
DAR
$5.07B
| $12.4M | 0.03% |
266,288
+190,988
| +254% | +$8.88M |
|
528
Macerich
MAC
$4.74B
| $12.3M | 0.03% |
712,979
+186,454
| +35% | +$3.21M |
|
529
Maravai LifeSciences
MRVI
$363M
| $12.2M | 0.03% |
1,410,362
+459,162
| +48% | +$3.98M |
|
530
Wave Life Sciences
WVE
$1.32B
| $12.2M | 0.03% |
1,974,737
-1,238,763
| -39% | -$7.64M |
|
531
Portillo's
PTLO
$490M
| $12.2M | 0.03% |
857,780
+319,146
| +59% | +$4.53M |
|
532
Corteva
CTVA
$49.1B
| $12.1M | 0.03% |
209,551
-1,192,057
| -85% | -$68.7M |
|
|
ITCI
533
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12M | 0.03% |
+173,766
| New | +$12M |
|
|
SAGE
534
DELISTED
Sage Therapeutics
SAGE
| $12M | 0.03% |
+641,211
| New | +$12M |
|
535
HealthEquity
HQY
$7.88B
| $12M | 0.03% |
146,754
-330,624
| -69% | -$27M |
|
536
Xenon Pharmaceuticals
XENE
$3.02B
| $11.9M | 0.03% |
275,859
-599,206
| -68% | -$25.8M |
|
|
CDMO
537
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $11.8M | 0.03% |
1,768,317
+1,258,486
| +247% | +$8.43M |
|
538
Perrigo
PRGO
$3.12B
| $11.8M | 0.03% |
367,900
-23,000
| -6% | -$740K |
|
|
JBIO
539
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| $11.8M | 0.03% |
11,424
-1,190
| -9% | -$1.23M |
|
540
Ventas
VTR
$30.9B
| $11.8M | 0.03% |
271,400
-29,145
| -10% | -$1.27M |
|
541
Chemours
CC
$2.34B
| $11.7M | 0.03% |
446,092
+131,792
| +42% | +$3.46M |
|
542
Fate Therapeutics
FATE
$116M
| $11.6M | 0.03% |
1,584,300
-1,904,863
| -55% | -$14M |
|
543
Expro
XPRO
$1.43B
| $11.6M | 0.03% |
581,024
+313,600
| +117% | +$6.26M |
|
544
ACV Auctions
ACVA
$2.03B
| $11.5M | 0.03% |
615,088
-403,392
| -40% | -$7.57M |
|
545
Amphastar Pharmaceuticals
AMPH
$1.37B
| $11.5M | 0.03% |
+262,400
| New | +$11.5M |
|
546
Alexandria Real Estate Equities
ARE
$14.5B
| $11.4M | 0.03% |
+88,648
| New | +$11.4M |
|
547
Arcturus Therapeutics
ARCT
$485M
| $11.3M | 0.03% |
335,378
+317,800
| +1,808% | +$10.7M |
|
548
Cousins Properties
CUZ
$4.95B
| $11.3M | 0.03% |
469,500
-70,000
| -13% | -$1.68M |
|
|
B
549
Barrick Mining Corporation
B
$48.5B
| $11.3M | 0.03% |
676,602
-51,404
| -7% | -$855K |
|
550
Ally Financial
ALLY
$12.7B
| $11.2M | 0.03% |
+276,854
| New | +$11.2M |
|